9.70
0.00
(0.00%)
At close: January 22 at 8:00:32 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,464,254.00
1,963,896.00
1,352,013.00
907,957.00
924,639.00
Cost of Revenue
2,070,985.00
1,503,426.00
1,035,429.00
657,551.00
696,581.00
Gross Profit
393,269.00
460,470.00
316,584.00
250,406.00
228,058.00
Operating Expense
415,453.00
481,525.00
336,464.00
279,536.00
271,247.00
Operating Income
-22,184.00
-21,055.00
-19,880.00
-29,130.00
-43,189.00
Net Non Operating Interest Income Expense
-23,005.00
-48,949.00
-14,203.00
-25,018.00
-25,692.00
Other Income Expense
-41,991.00
-132,401.00
-27,994.00
24,347.00
-261,659.00
Pretax Income
-87,180.00
-202,405.00
-62,077.00
-29,801.00
-330,540.00
Tax Provision
-14,948.00
-89,365.00
-43,376.00
483.00
-2,368.00
Net Income Common Stockholders
-104,234.00
-142,260.00
-19,164.00
-37,601.00
-334,246.00
Diluted NI Available to Com Stockholders
-104,234.00
-142,260.00
-19,164.00
-37,601.00
-334,246.00
Basic EPS
-0.92
-1.28
-0.20
-0.44
-3.94
Diluted EPS
-0.92
-1.28
-0.20
-0.44
-3.94
Basic Average Shares
114,326.75
111,251.00
93,699.00
86,067.00
84,928.00
Diluted Average Shares
114,326.75
111,251.00
93,699.00
86,067.00
84,928.00
Total Operating Income as Reported
-43,239.00
-71,211.00
3,642.00
-42,411.00
-262,847.00
Total Expenses
2,486,438.00
1,984,951.00
1,371,893.00
937,087.00
967,828.00
Net Income from Continuing & Discontinued Operation
-72,232.00
-113,040.00
-19,164.00
-37,601.00
-334,246.00
Normalized Income
-37,379.52
-56,818.86
-29,231.70
-5,008.48
-58,493.06
Interest Income
7,235.00
5,256.00
1,369.00
407.00
2,633.00
Interest Expense
30,240.00
54,205.00
15,572.00
25,425.00
28,325.00
Net Interest Income
-23,005.00
-48,949.00
-14,203.00
-25,018.00
-25,692.00
EBIT
-56,940.00
-148,200.00
-46,505.00
-4,376.00
-302,215.00
EBITDA
61,736.00
-24,785.00
20,690.00
55,661.00
-240,740.00
Reconciled Cost of Revenue
2,070,985.00
1,503,426.00
1,035,429.00
657,551.00
695,941.00
Reconciled Depreciation
118,676.00
123,415.00
67,195.00
60,037.00
61,475.00
Net Income from Continuing Operation Net Minority Interest
-72,232.00
-113,040.00
-18,701.00
-30,284.00
-328,172.00
Total Unusual Items Excluding Goodwill
-42,065.00
-71,166.00
13,330.00
-34,624.00
-271,580.00
Total Unusual Items
-42,065.00
-71,166.00
13,330.00
-34,624.00
-271,580.00
Normalized EBITDA
103,801.00
46,381.00
7,360.00
90,285.00
30,840.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-7,212.52
-14,944.86
2,799.30
-9,348.48
-1,901.06
12/31/2020 - 6/8/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
L7T.F Unidoc Health Corp.
0.2900
-4.61%
BTSGU BrightSpring Health Services, Inc.
75.66
+1.79%
PHR Phreesia, Inc.
27.22
-0.48%
MPLN MultiPlan Corporation
16.00
+1.91%
HCAT Health Catalyst, Inc.
5.61
-1.23%
ACCD Accolade, Inc.
6.89
+0.15%
HQY HealthEquity, Inc.
105.77
+0.98%
TXG 10x Genomics, Inc.
16.31
+0.93%
SDGR Schrödinger, Inc.
24.34
+14.11%
TEM Tempus AI, Inc
50.45
+5.90%